(Q58494225)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457835&resulttype=core&format=json

13 May 2020

1 reference

Ido D Fabian

1

0 references

Mandeep S. Sagoo

object named as

Mandeep S Sagoo

4

0 references

author name string

Kenneth P Johnson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457835&resulttype=core&format=json

13 May 2020

Andrew W Stacey

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457835&resulttype=core&format=json

13 May 2020

M A Reddy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457835&resulttype=core&format=json

13 May 2020

Ido D Fabian

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457835&resulttype=core&format=json

13 May 2020

Mandeep S Sagoo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457835&resulttype=core&format=json

Cochrane Database of Systematic Reviews

13 May 2020

publication date

28 September 2016

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457835&resulttype=core&format=json

13 May 2020

volume

2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457835&resulttype=core&format=json

13 May 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457835&resulttype=core&format=json

Presenting signs of retinoblastoma

13 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma: technique and predictors of success

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Visual fields in retinoblastoma survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Treatment of Retinoblastoma in 2015: Agreement and Disagreement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Outcome of retinoblastoma in east Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Combined chemotherapy and local treatment in the management of intraocular retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Drug cytotoxicity at elevated temperature. In vitro study on the U-87MG glioma cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

The Incidence of Trilateral Retinoblastoma: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Preradiation intracarotid cisplatin treatment of newly diagnosed anaplastic gliomas. The CNS Cancer Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Mortality from second tumors among long-term survivors of retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Lifetime risks of common cancers among retinoblastoma survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Retinoblastoma treated with primary chemotherapy alone: the significance of tumour size, location, and age

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Eye-preservation treatment of retinoblastoma with vitreous seeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Mutation and cancer: statistical study of retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Chorioretinal scar growth after 810-nanometer laser treatment for retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Chemothermotherapy in the management of retinoblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Retinoblastoma in Great Britain 1963-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Late presentation of retinoblastoma in Malaysia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Chemotherapy plus local treatment in the management of intraocular retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Published international classification of retinoblastoma (ICRB) definitions contain inconsistencies--an analysis of impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Cerebrospinal fluid pharmacokinetics of carboplatin in children with brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Intravitreal chemotherapy for recurrent retinoblastoma in an only eye

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Chemoreduction in the initial management of intraocular retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Continuing challenges in the management of retinoblastoma with chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Irradiation of retinoblastoma (glioma retinae).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Whole body hyperthermia and carboplatin: cytotoxicity for murine leukaemia and normal marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

Multiagent chemotherapy as neoadjuvant treatment for multifocal intraocular retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012366

10.1002/14651858.CD012366

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457835&resulttype=core&format=json

13 May 2020

1 reference